ConductScience.org, home

Paper42428883

Design and Synthesis of Novel Chalcogen-1,2,4-triazoles as Lead-like Glutathione Peroxidase-Mimetic Antioxidants.

Santos NLB and 5 others. ACS Omega, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Design and Synthesis of Novel Chalcogen-1,2,4-triazoles as Lead-like Glutathione Peroxidase-Mimetic Antioxidants. Papers, record 42428883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42428883

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Design and Synthesis of Novel Chalcogen-1,2,4-triazoles as Lead-like Glutathione Peroxidase-Mimetic Antioxidants.
PubMed
Journal
ACS Omega
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Santos NLBNathália L B
2Gomes LSLuana S
3Sá NBNathalia B
4Cordeiro PPâmella
5S de Oliveira AAldohttps://orcid.org/0000-0001-7760-4484
6Nascimento VVanessahttps://orcid.org/0000-0001-9413-7638

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134846405Glutathione peroxidase mimics based on conformationally-restricted, peri-like, 4,5-disubstituted fluorene dichalcogenides.Org Biomol Chem2021https://conductscience.org/library/papers/34846405PubMed
239880296Chalcogen dihydrobenzofuran compounds as potential neuroprotective agents: An in vitro and in silico biological investigation.Biochimie2025https://conductscience.org/library/papers/39880296PubMed
338293899Aminic Organoselenium Compounds as Glutathione Peroxidase Mimics and Inhibitors of Ferroptosis.Chembiochem2024https://conductscience.org/library/papers/38293899PubMed
436226121Synthesis methods of 1,2,3-/1,2,4-triazoles: A review.Front Chem2022https://conductscience.org/library/papers/36226121PubMed
533655868Diselenides and Selenocyanates as Versatile Precursors for the Synthesis of Pharmaceutically Relevant Compounds.Curr Org Synth2022https://conductscience.org/library/papers/33655868PubMed
639711134Organoselenium compounds beyond antioxidants.Future Med Chem2024https://conductscience.org/library/papers/39711134PubMed
729168872Organoselenium compounds as mimics of selenoproteins and thiol modifier agents.Metallomics2017https://conductscience.org/library/papers/29168872PubMed
828489107A novel metal-free method for the selenocyanation of aromatic ketones to afford α-carbonyl selenocyanates.Org Biomol Chem2017https://conductscience.org/library/papers/28489107PubMed
915231062In vitro evaluation of glutathione peroxidase (GPx)-like activity and antioxidant properties of some Ebselen analogues.Redox Rep2004https://conductscience.org/library/papers/15231062PubMed
1034932346How Solvation Influences the SN2 versus E2 Competition.J Org Chem2022https://conductscience.org/library/papers/34932346PubMed
1125244678Synthesis and biological evaluation of new nitrogen-containing diselenides.Eur J Med Chem2014https://conductscience.org/library/papers/25244678PubMed
1228471109Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis.J Zhejiang Univ Sci B2017https://conductscience.org/library/papers/28471109PubMed
1330043018Ion-pairing catalysis in the enantioselective addition of hydrazones to N-acyldihydropyrrole derivatives.Chem Commun (Camb)2018https://conductscience.org/library/papers/30043018PubMed
1421247117Open vessel and cooling while heating microwave-assisted synthesis of pyridinyl N-aryl hydrazones.ACS Comb Sci2011https://conductscience.org/library/papers/21247117PubMed
1537478558Recent advances in 1,2,3- and 1,2,4-triazole hybrids as antimicrobials and their SAR: A critical review.Eur J Med Chem2023https://conductscience.org/library/papers/37478558PubMed
1639026642Design, synthesis, and structure-activity relationship studies of 6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazole derivatives as necroptosis inhibitors.RSC Med Chem2024https://conductscience.org/library/papers/39026642PubMed
1738871111Selenium-containing compounds: a new hope for innovative treatments in Alzheimer's disease and Parkinson's disease.Drug Discov Today2024https://conductscience.org/library/papers/38871111PubMed
1840766767Synthetic and semi-synthetic antioxidants in medicine and food industry: a review.Front Pharmacol2025https://conductscience.org/library/papers/40766767PubMed
1934044345Bifunctional chiral selenium-containing 1,4-diarylazetidin-2-ones with potent antitumor activities by disrupting tubulin polymerization and inducing reactive oxygen species production.Eur J Med Chem2021https://conductscience.org/library/papers/34044345PubMed
2024752799Design, synthesis and evaluation of seleno-dihydropyrimidinones as potential multi-targeted therapeutics for Alzheimer's disease.Org Biomol Chem2014https://conductscience.org/library/papers/24752799PubMed

See all 40 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42428883

GET https://conductscience.org/api/papers/v1/42428883/references?page=2